Alex Fässler
Direttore operativo presso Targimmune Therapeutics AG
Patrimonio netto: 3 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Alex Fässler
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Alex Fässler tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder | |
Credit Suisse (USA), Inc.
Credit Suisse (USA), Inc. Investment Banks/BrokersFinance Credit Suisse (USA), Inc. provides investment services. It offers securities underwriting and trading, mergers & acquisitions advice, research, private equity investment & derivative, and risk management services. The company was founded in 1959 and is headquartered in New York, NY. | Investment Banks/Brokers | Corporate Officer/Principal | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
Congenia Srl
Congenia Srl Miscellaneous Commercial ServicesCommercial Services Congenia SRL operates as pharmaceutical company, is engaged in the development of novel therapeutics for diseases associated with mitochondrial stress-induced dysfunction. The company develops small molecule drugs that target the mitochondrial permeability transition pore, a protein channel with various macromolecular components that along with mitochondrial protein p66, appears to be associated with oxidative stress-induced cell death. The company was founded in 2004 by Saverio Minucci, Pier Giuseppe Pelicci, Marco Giorgio and Paolo Bernardi and is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Credit Suisse AG
Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Investment Managers | Corporate Officer/Principal | |
TESSELLIS S.P.A. | Major Telecommunications | Director/Board Member | |
BACHEM HOLDING AG | Pharmaceuticals: Major | Chairman | |
Sunstar-Holding AG
Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Hotels/Resorts/Cruise lines | Chairman | |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Fastweb SpA
Fastweb SpA Major TelecommunicationsCommunications Fastweb SpA engages in the provision of solutions for internet connectivity. The firm offers a wide range of voice and data services, fixed communication, and mobile to households and businesses. It also constructs fiber optic network infrastructure and adopts internet protocol for voice, data, and video transmission. The company was founded by Silvio Scaglia in September 1999 and is headquartered in Milan, Italy. | Major Telecommunications | Corporate Officer/Principal | |
The Hebrew University of Jerusalem | College/University | Corporate Officer/Principal | |
University of Basel | College/University | Doctorate Degree | |
University of Bocconi | College/University | Undergraduate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
SPEXIS AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Institute for Advanced Studies In Aging & Geriatric Medi | Director/Board Member | ||
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Director/Board Member | |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Medical Specialties | Founder | |
ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
Genextra SpA
Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Chief Executive Officer | |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Medical Specialties | Director/Board Member | |
Bachem Americas, Inc.
Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Pharmaceuticals: Major | Chairman | |
Harlan Laboratories Ltd.
Harlan Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Laboratory Corp. of America Holdings, Harlan Laboratories Ltd. provides non-clinical contract research, research models and animal diets services to pharmaceutical, biotech, medical device, agrochemical and chemical industry. The company is based in Itingen, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Israel Academy of Sciences & Humanities
Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services The Israel Academy of Sciences & Humanities is the national academy of science in Israel. The private company is based in Jerusalem, Israel. The academy sees the promotion and developer of the basic scientific research system of a target of national importance. Founded in 1961, its aim is to concentrate on the best of personal science residents, nurturing and promoting scientific activity, advising the government on research and scientific planning of national importance, having contact with parallel bodies outside-to represent Israeli science in institutions and in international conferences and publish reporters to promote science. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Chief Executive Officer | |
University of Applied Sciences Basel | College/University | Undergraduate Degree | |
Ferienclub Privilège AG | Director/Board Member | ||
Alusuisse-Lonza America, Inc. | Director of Finance/CFO | ||
Caperis Partners AG | Corporate Officer/Principal | ||
Applango USA, Inc.
Applango USA, Inc. Packaged SoftwareTechnology Services Applango USA, Inc. develops salesforce applications. It offers Appalango for Adaption which empowers sales managers, tracks usage over time, identifies the frequency of user updates, and pinpoints issues and areas of improvement. The company was founded by Daniel Sarfati in 2012 and is headquartered in Stamford, CT. | Packaged Software | Director/Board Member | |
PDS Pathology Data Systems Co. Ag | Chairman | ||
Applango Systems Ltd.
Applango Systems Ltd. Packaged SoftwareTechnology Services Applango Systems Ltd. develops software tools for enterprise organizations. It offers Appalango for Adaption which empowers sales managers, tracks usage over time, identifies the frequency of user updates, and pinpoints issues and areas of improvement. The company was founded by Daniel Sarfati in 2012 and is headquartered in Tel Aviv, Israel. | Packaged Software | Director/Board Member | |
GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
Dac SRL
Dac SRL Motor VehiclesConsumer Durables Dac SRL is an Italian company that manufactures and sells car, bike, motorbike accessories, and spare parts. The private company is based in Cavriago, Italy. | Motor Vehicles | Corporate Officer/Principal | |
InnovHeart Srl
InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Medical Specialties | Director/Board Member | |
Data Systems AG | Chairman | ||
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Investment Managers | Founder | |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Biotechnology | Chairman |
Statistiche
Distribuzione geografica
Svizzera | 20 |
Stati Uniti | 14 |
Italia | 12 |
Israele | 7 |
Regno Unito | 2 |
Settori
Health Technology | 21 |
Consumer Services | 8 |
Finance | 7 |
Commercial Services | 6 |
Communications | 3 |
Posizioni
Director/Board Member | 39 |
Corporate Officer/Principal | 24 |
Chairman | 11 |
Founder | 10 |
Director of Finance/CFO | 9 |
Contatti più connessi
Insiders | |
---|---|
Peter Morgan Kash | 32 |
Kuno Sommer | 17 |
Paolo Fundarò | 17 |
Andreas Emmenegger | 14 |
Christoph Rentsch | 10 |
Alexander Levitzki | 8 |
Esteban Pombo-Villar | 4 |
Peter Braun | 1 |
- Borsa valori
- Insiders
- Alex Fässler
- Connessioni Società